Physician

Andrew Craig Hirsch, M.D.

According to 2025 Medicare claims, Andrew Hirsch, M.D. (NPI: 1275588972) practices allergy/immunology in the Lakewood-New Brunswick, NJ market, with the plurality of this provider's patient population coming from Monmouth, NJ. This provider's primary affiliated billing organization is ALLERGY & ASTHMA ASSOCIATES, INC. (NPI: 1346425626; TIN: 223251602) and primary practice location at 07701-2035.

Hirsch's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 281 traditional Medicare patients, billed 7,629 HCPCS/CPT codes, and received $108,190 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 1,289 prescription claims across 237 beneficiaries totaling $318,851 in drug costs, led by Dupixent Pen (Dupilumab). DME data shows 127 claims. Open Payments data shows 105 records totaling $2,333. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing did not follow a clear longitudinal pattern. Concurrently, Part D prescription costs have risen steadily, from $136,128 to $318,851. In contrast, DME billing represents a smaller volume and moved sharply higher in recent years, from $757 to $1,917.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	291	6,301	$103,259
2016	308	6,171	$101,148
2017	264	5,091	$82,703
2018	302	5,807	$88,837
2019	268	5,488	$83,017
2020	251	5,133	$72,520
2021	249	4,916	$80,812
2022	257	6,407	$113,907
2023	275	7,468	$116,912
2024	281	7,629	$108,190

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	176	921	$136,128
2016	174	861	$136,529
2017	185	883	$125,142
2018	210	1,049	$176,425
2019	208	1,006	$199,295
2020	196	1,091	$226,908
2021	190	1,088	$207,886
2022	206	1,048	$163,325
2023	226	1,088	$199,512
2024	237	1,289	$318,851

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	75	$45,574
2016	N/R	101	$77,829
2017	N/R	90	$55,967
2018	N/R	89	$55,928
2019	N/R	105	$127,004
2020	N/R	120	$145,153
2021	N/R	65	$93,167
2022	N/R	58	$440,712
2023	N/R	65	$412,165
2024	N/R	127	$172,850

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	95	148	$102
99203	New patient office or other outpatient visit with low level of medical decision making, if using time, 30 minutes or more	79	79	$87
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	120	284	$72
94375	Test to measure rate of airflow	81	113	$33
95004	Test for allergy using allergenic extract	80	3,439	$3

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Dupixent Pen	Dupilumab	22	616	$80,821
Xolair	Omalizumab	28	784	$73,652
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	72	3,180	$62,344
Breztri Aerosphere	Budesonide/Glycopyr/Formoterol	28	1,080	$21,053
Breo Ellipta	Fluticasone/Vilanterol	22	720	$9,631

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
J1559	Injection, immune globulin (hizentra), 100 mg	N	N/R	19	$63,118
J1459	Injection, immune globulin (privigen), intravenous, non-lyophilized (e.g., liquid), 500 mg	N	N/R	13	$39,437
J1551	Injection, immune globulin (cutaquig), 100 mg	N	N/R	11	$39,359
J1575	Injection, immune globulin/hyaluronidase, (hyqvia), 100 mg immuneglobulin	N	N/R	12	$24,230
Q2052	Services, supplies and accessories used in the home for the administration of intravenous immune globulin (ivig)	N	N/R	15	$4,945

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	105	$2,333	AstraZeneca Pharmaceuticals LP
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Andrew Craig Hirsch, M.D.?

Tedicare shows public-source Medicare data for Andrew Craig Hirsch, M.D. (NPI 1275588972), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Andrew Craig Hirsch, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Andrew Craig Hirsch, M.D.?

Andrew Craig Hirsch, M.D. is linked to ALLERGY & ASTHMA ASSOCIATES, INC. (billing NPI 1346425626) in the available physician profile data.

Does Andrew Craig Hirsch, M.D. have Open Payments data?

Andrew Craig Hirsch, M.D. has 105 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.